About Bay City Capital
Bay City Capital is a venture capital firm founded in 1997. It is primarily based out of San Francisco, United States. As of May 2021, Bay City Capital has invested in 94 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it led the $20.5M Series B round of Oculis along with Novartis Venture Fund. This round also saw participation from Brunnur Ventures and other investors.
Overall, Bay City Capital portfolio has seen 1 unicorn, 21 IPOs and 45 acquisitions including key companies like Nevro, PTC Therapeutics and Fabric Genomics. A lot of funds co-invest with Bay City Capital, with names like New Enterprise Associates sharing a substantial percentage of its portfolio.
Bay City Capital has team of 10 people including 5 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B &
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Bay City Capital's Year-on-Year Investment Trends
Bay City Capital has invested in 94 companies over the last 28 years, with an average of 1 new investment annually in the last 10 years. Its most recent first time investment was in Xilio Therapeutics and most recent follow-on round was in Oculis.
Year | No. of Investments | ||
|---|---|---|---|
1stÌý¸é´Ç³Ü²Ô»å | Follow-on | Total | |
2025 (YTD) | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 |
2021 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2018 | 5 | 0 | 5 |
2017 | 4 | 0 | 4 |
2016 | 2 | 2 | 4 |
Get Bay City Capital's portfolio delivered to your inbox!
Bay City Capital's Investment Trends by Stage
Bay City Capital has made 17 investments in Series A stage with an average round size of $21.5M, 15 investments in Series B stage with an average round size of $40.5M and 8 investments in Series C stage with an average round size of $44.4M.Note: We have considered here, only first round of investments
Stage of entry | No. of Investments |
|---|---|
Series A | 17 |
Series B | 15 |
Series C | 8 |
Post IPO | 4 |
Series D | 4 |
Others | 13 |
Bay City Capital's Investment Trends by Sector
Bay City Capital has a diverse portfolio, with companies operating in the Life Sciences, Healthcare, High Tech, Consumer and HealthTech. Notably, it has invested in 77 Tech companies, 57 Enterprise (B2B) companies, 7 Tech hardware companies and at least 4 companies focusing on Consumer (B2C).
Note: We have considered here, only first round of investments
Sector | No. of Investments |
|---|---|
Life Sciences | 49 |
Healthcare | 10 |
High Tech | 7 |
Consumer | 6 |
HealthTech | 6 |
Others | 13 |
Bay City Capital's Investment Trends by Geography
Bay City Capital has made most investments in United States (83), followed by Australia where it has made 1 investments.
Note: We have considered here, only first round of investments
Country | No. of Investments |
|---|---|
United States | 56 |
Australia | 1 |
Ireland | 1 |
Netherlands | 1 |
Spain | 1 |
Others | 1 |
Bay City Capital's recent investments
Here are the most recent investments by Bay City Capital:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 04, 2021 | Switzerland | Series C | $57M | BioVeda China Fund [+9] | |
Mar 02, 2020 | United States | Series B | $100M | Takeda Ventures [+8] | |
Mar 18, 2019 | United States | Series B | $63M | Arix Bioscience [+7] | |
Nov 13, 2018 | United States | Series B | $93.4M | [+12] | |
Mar 02, 2018 | Ireland | Series B | $78.1M | Arix Bioscience [+7] |
Get the detailed list of all investments by Bay City Capital. Download now!Unicorns in Bay City Capital's Portfolio
Here is a list of unicorns in Bay City Capital's portfolio:
ÃØÃÜÑо¿Ëù Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
33 | Provider of osmotic pump for subcutaneous drug delivery | 1995 | Boston | Series J | eqgrser |
IPOs and Publicly Listed companies in Bay City Capital's Portfolio
Here are Bay City Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 03, 2023 | Jan 04, 2018 | Series B | $20.5M | |
Oct 22, 2021 | Mar 02, 2020 | Series B | $100M | |
Oct 29, 2020 | - | - | - | |
Mar 12, 2020 | Apr 14, 2016 | Series A | $31M | |
May 09, 2019 | Nov 13, 2018 | Series B | $93.4M |
Acquired companies in Bay City Capital's Portfolio
Here are Bay City Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 16, 2025 | Jan 07, 2014 | Series A | $8.3M | |
Feb 06, 2025 | Dec 04, 2006 | Seed | $5.5M | |
Oct 21, 2024 | Jun 03, 2013 | Series E | $45.5M | |
Aug 01, 2024 | Mar 14, 2013 | Series D | $35M | |
Feb 12, 2024 | Aug 27, 2003 | Series C | $27M |
Team profile of Bay City Capital
Bay City Capital has a team of 10 membersÌýincluding 5 Partners, 1 Venture Partner and 3 PrincipalsÌýlocated in United States and Switzerland. Bay City Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Bay City Capital:
Name | Designation | Location | Board Memberships | Contact details |
|---|---|---|---|---|
Partner | San Francisco | - | ||
Partner | Zug | - | ||
Partner | San Francisco | - | ||
Partner | San Francisco | - | ||
Partner | San Francisco | - | ||
Venture Partner | San Francisco | - | ||
Principal | San Francisco | - | ||
Principal | San Francisco | - | ||
Principal | San Francisco | - |
Get the full list of Bay City Capital's team & partners for free. Download now!Co-investors of Bay City Capital
Over the past 28 years, 358 investors have co-invested in Bay City Capital's portfolio companies.
- Invested before Bay City Capital:ÌýSofinnova Investments, Canaan and 83 others have invested in rounds before Bay City Capital. There are 4 companies where Sofinnova Investments has invested before Bay City Capital and 3 companies where Canaan has invested before Bay City Capital.
- Top Co-investors of Bay City Capital:Ìý147 investors entered a company along with Bay City Capital. These include investors like New Enterprise Associates (6 companies).
- Invested after Bay City Capital:ÌýA total of 126 investors have invested in Bay City Capital's portfolio after their investments. Top Investors include New Enterprise Associates (5 companies), Rock Springs Capital (5 companies) and RA Capital Management (5 companies).
Get full list of Bay City Capital's co-investors delivered to your inbox!
Recent News related to Bay City Capital
•
•
Eyewire•May 04, 2021•Oculis, BioVeda China Fund, Hyfinity Investments, VI Partners and 10 others
•
•
Fierce Biotech•Mar 02, 2020•Xilio Therapeutics, Takeda Ventures, F-Prime Capital, Atlas Venture and 7 others
•
•
Business Wire•Mar 18, 2019•Imara, Arix Bioscience, New Enterprise Associates, Pfizer and 6 others
•
•
•
PR Newswire•Jan 04, 2018•Oculis, Bay City Capital, Novartis Venture Fund, Pivotal bioVenture Partners China and 8 others
•
